• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$20.57 -$0.08 (-0.39%)

REAL-TIME: Last trade at

Seattle Genetics, Inc.

NASDAQ:SGEN

Jump to this page for:

Related Resources

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 2

5/25/2012 by Seeking Alpha

The Meaningless Drug Approval That Could Cost the Industry Billions

5/25/2012 by DailyFinance

Finding a Pathway to Approval

5/24/2012 by DailyFinance

An Early Look at 2012 ASCO Biotech Cancer Stocks (DNDN, LLY, AMGN, ARIA, ARQL, ARRY, AVEO, BVTI, ABP

5/18/2012 by 247wallst

Ariad Pharmaceuticals, ArQule, Exelixis, Aveo, Other Cancer Drug Stocks Fall

5/17/2012 by Minyanville

Taking An Early Look at 2012 ASCO Biotech/Cancer Stocks (DNDN, LLY, ARIA, ARRY, BVTI, ABPI, CLDX, CY

5/10/2012 by 247wallst

Why Seattle Genetics Shares Dropped Then Rallied

5/9/2012 by DailyFinance

It's Fashionably Late, but This Biotech's Party Is Just Starting

4/13/2012 by DailyFinance

Here's What This Massive Money Manager Is Buying

3/27/2012 by DailyFinance

Early Submission = 60% Pop

3/16/2012 by DailyFinance

How Many Drug Sales in 2012?

2/14/2012 by DailyFinance

Biotech Investors Confident: Industry Sees Big VC Spending in 2011

1/25/2012 by DailyFinance

Don't Read Too Much Into This Partnership

1/18/2012 by DailyFinance

Warning: Don't Sell on This News

1/15/2012 by DailyFinance

FDA Warns On Serious Brain Infection Risk With Lymphoma Drug Adcetris

1/13/2012 by Smart Money

The Magic Formula for Biotech

1/13/2012 by DailyFinance

Don't Read Too Much Into This Partnership

1/6/2012 by DailyFinance

JPMorgan Confab Kicks Off Biotech 2012

1/5/2012 by Minyanville

Are These Biotech Drug Launches Back on Track?

1/5/2012 by DailyFinance

Biotech Ideas: Top Biotech Stocks with Bullish Institutional Trends

1/4/2012 by DailyFinance

What to Look For With Seattle Genetics in 2012

12/29/2011 by DailyFinance

Health Care's Worst Stocks 2011: Dendreon

12/23/2011 by DailyFinance

ARIAD's Prolific 2011

12/19/2011 by DailyFinance

Is Pharmacyclics the Perfect Stock?

12/12/2011 by DailyFinance

Why Biotech Investors Must Understand the FDA's Adverse Events Reports

12/6/2011 by Minyanville

Health Care's 5 Worst November Flops

11/30/2011 by DailyFinance

Seattle Genetics is Oversold, Analyst Says

11/28/2011 by Minyanville

I Was Wrong About Dendreon

11/23/2011 by DailyFinance

How to Cut Your Taxes by $15 Million

11/18/2011 by DailyFinance

5 Insider Stock Picks that Predictive Analysts Expect to Outperform

11/16/2011 by Nasdaq

5 Insider Stock Picks that Predictive Analysts Expect to Outperform

11/15/2011 by DailyFinance

A Sell-the-News Buying Opportunity

11/8/2011 by DailyFinance

This Biotech Thinks It's Cheap

11/8/2011 by DailyFinance

Seattle Genetics Frontline Trial Plans Are Not New -- and Not a Problem, Either

11/4/2011 by Minyanville

Has Baxter International Become the Perfect Stock?

11/3/2011 by DailyFinance

Bullish Outlook: 10 Stocks Near Highs, Boosted by Insider Buying

11/1/2011 by DailyFinance

Make Money in Promising Biotech Stocks the Easy Way

10/26/2011 by DailyFinance

This Just In: Upgrades and Downgrades

10/6/2011 by DailyFinance

Upgrades & Downgrades: Raising The Roof On REITs

10/4/2011 by Minyanville

3 Stocks Approaching Greatness

9/30/2011 by DailyFinance
See More Articles...